InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218
$29.89 +2.01% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $29.89 −43.08% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue6.8Operating income−132.9Fiscal year 2017Revenue12.7 +87.8%Operating income−121.5Fiscal year 2018Revenue9.5 −25.2%Operating income−156.4Fiscal year 2019Revenue3.6 −62.5%Operating income−55.0EPS, diluted−3.51Fiscal year 2020Revenue7.4 +107.6%Operating income−63.4EPS, diluted−2.02Fiscal year 2021Revenue4.7 −37.3%Operating income−71.2EPS, diluted−1.64Fiscal year 2022Revenue2.4 −49.3%Operating income−115.2EPS, diluted−2.40Fiscal year 2023Revenue6.9 +192.0%Operating income−154.5Net income−141.4EPS, diluted−2.92Fiscal year 2024Revenue7.0 +2.0%Operating income−195.1Net income−157.9EPS, diluted−2.45Fiscal year 2025Revenue1.5 −78.0%Operating income−287.4Net income−258.8EPS, diluted−3.90
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 6.8 12.7 9.5 3.6 7.4 4.7 2.4 6.9 7.0 1.5
Growth +87.8% −25.2% −62.5% +107.6% −37.3% −49.3% +192.0% +2.0% −78.0%
Operating income −132.9 −121.5 −156.4 −55.0 −63.4 −71.2 −115.2 −154.5 −195.1 −287.4
Net income n/a n/a n/a n/a n/a n/a n/a −141.4 −157.9 −258.8
Growth
EPS, diluted n/a n/a n/a −3.51 −2.02 −1.64 −2.40 −2.92 −2.45 −3.90

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,958.7%Free cash flow margin−1,706.3%Fiscal year 2017Operating margin−953.7%Free cash flow margin−798.2%Fiscal year 2018Operating margin−1,640.1%Free cash flow margin−797.3%Fiscal year 2019Operating margin−1,540.2%Free cash flow margin−1,319.5%Fiscal year 2020Operating margin−854.1%Free cash flow margin−565.6%Fiscal year 2021Operating margin−1,531.8%Free cash flow margin−1,336.4%Fiscal year 2022Operating margin−4,889.0%Free cash flow margin−4,478.6%Fiscal year 2023Operating margin−2,245.3%Net margin−2,054.8%Free cash flow margin−1,585.2%Fiscal year 2024Operating margin−2,778.9%Net margin−2,248.8%Free cash flow margin−2,274.9%Fiscal year 2025Operating margin−18,599.8%Net margin−16,748.0%Free cash flow margin−13,829.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,958.7% −953.7% −1,640.1% −1,540.2% −854.1% −1,531.8% −4,889.0% −2,245.3% −2,778.9% −18,599.8%
Net margin n/a n/a n/a n/a n/a n/a n/a −2,054.8% −2,248.8% −16,748.0%
Free cash flow margin −1,706.3% −798.2% −797.3% −1,319.5% −565.6% −1,336.4% −4,478.6% −1,585.2% −2,274.9% −13,829.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−113.0Capital expenditure−2.8Free cash flow−115.8Fiscal year 2017Operating cash flow−99.9Capital expenditure−1.8Free cash flow−101.7Fiscal year 2018Operating cash flow−75.2Capital expenditure−0.8Free cash flow−76.0Fiscal year 2019Operating cash flow−46.4Capital expenditure−0.7Free cash flow−47.1Fiscal year 2020Operating cash flow−40.4Capital expenditure−1.6Free cash flow−42.0Fiscal year 2021Operating cash flow−60.9Capital expenditure−1.2Free cash flow−62.2Fiscal year 2022Operating cash flow−103.7Capital expenditure−1.8Free cash flow−105.6Fiscal year 2023Operating cash flow−107.3Capital expenditure−1.8Free cash flow−109.1Fiscal year 2024Operating cash flow−157.8Capital expenditure−1.9Free cash flow−159.7Fiscal year 2025Operating cash flow−210.9Capital expenditure−2.7Free cash flow−213.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −113.0 −99.9 −75.2 −46.4 −40.4 −60.9 −103.7 −107.3 −157.8 −210.9
Capital expenditure −2.8 −1.8 −0.8 −0.7 −1.6 −1.2 −1.8 −1.8 −1.9 −2.7
Free cash flow −115.8 −101.7 −76.0 −47.1 −42.0 −62.2 −105.6 −109.1 −159.7 −213.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash42.5Shareholders’ equity265.4Fiscal year 2017Cash40.3Shareholders’ equity236.4Fiscal year 2018Cash24.3Shareholders’ equity124.1Fiscal year 2019Cash11.2Shareholders’ equity94.0Fiscal year 2020Cash43.8Shareholders’ equity209.4Fiscal year 2021Cash39.1Shareholders’ equity419.5Fiscal year 2022Cash29.4Shareholders’ equity326.2Fiscal year 2023Cash34.8Shareholders’ equity429.2Fiscal year 2024Cash28.4Shareholders’ equity747.0Fiscal year 2025Cash28.9Shareholders’ equity527.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 42.5 40.3 24.3 11.2 43.8 39.1 29.4 34.8 28.4 28.9
Shareholders’ equity 265.4 236.4 124.1 94.0 209.4 419.5 326.2 429.2 747.0 527.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
6.8 12.7 9.5 3.6 7.4 4.7 2.4 6.9 7.0 1.5
Growth +87.8% −25.2% −62.5% +107.6% −37.3% −49.3% +192.0% +2.0% −78.0%
1.6 0.7 0.7 0.1 0.2 0.1 0.1 0.3 0.2 0.2
102.7 96.2 66.4 42.7 42.5 53.3 82.3 118.0 163.6 245.1
36.0 25.0 19.3 15.4 14.5 20.5 27.2 30.9 38.5 43.8
−132.9 −121.5 −156.4 −55.0 −63.4 −71.2 −115.2 −154.5 −195.1 −287.4
Growth
−128.5 −117.3 −151.9 −50.9 −60.9 −70.7 −112.3 −141.4 −157.9 −258.8
n/a −24.3 −0.8 n/a −1.2 −0.2 n/a 0.0 0.0 0.0
n/a n/a n/a n/a n/a n/a n/a −141.4 −157.9 −258.8
Growth
Per share
n/a n/a n/a −3.51 −2.02 −1.64 −2.40 −2.92 −2.45 −3.90
n/a n/a n/a −3.51 −2.02 −1.64 −2.40 −2.92 −2.45 −3.90
Growth
n/a n/a n/a 0.0 0.0 0.0 0.0 48.4 64.4 66.4
n/a n/a n/a 0.0 0.0 0.0 0.0 48.4 64.4 66.4
Growth +104.3% +44.6% +9.4% +103,229.2% +32.9% +3.1%

† The diluted share count jumps at 2020 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 26.9% a year over five years.
  • Operating margin is down 17,745.7 points on five years ago, at -18,599.8%.
  • A net loss in 3 of 3 years on file.